Related Experiment Video
Updated: Oct 13, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
DPPA2, DPPA4, and other DPPA factor epigenomic functions in cell fate and cancer
Rachel Herndon Klein1, Paul S Knoepfler1
1Department of Cell Biology and Human Anatomy, University of California, Davis, CA 95616, USA; Institute of Pediatric Regenerative Medicine, Shriners Hospital for Children Northern California, Sacramento, CA 95817, USA; Genome Center, University of California, Davis, CA 95616, USA.
Abstract:
Many gene networks are shared between pluripotent stem cells and cancer; a concept exemplified by several DPPA factors such as DPPA2 and DPPA4, which are highly and selectively expressed in stem cells but also found to be reactivated in cancer. Despite their striking expression pattern, for many years the function of DPPA2 and DPPA4 remained a mystery; knockout of Dppa2 and Dppa4 did not affect pluripotency, but caused lung and skeletal defects late in development, long after Dppa2 and Dppa4 expression had been turned off. A number of recent papers have further clarified and defined the roles of these important factors, identifying roles in priming the chromatin and maintaining developmental competency through regulating both H3K4me3 and H3K27me3 at bivalent chromatin domains, and acting to remodel chromatin and facilitate reprogramming of somatic cells to induced pluripotency. These findings highlight an important regulatory role for DPPA2 and DPPA4 at the transitional boundary between pluripotency and differentiation and may have relevance to the functions of DPPA2 and 4 in the context of cancer cells as well.
Insights
DPPA2 and DPPA4 factors are crucial for maintaining developmental competency and chromatin regulation in stem cells. Their roles extend to cancer, highlighting their importance in pluripotency and differentiation transitions.
Area of Science:
- Developmental Biology
- Cancer Biology
- Epigenetics
Background:
- Gene networks in pluripotent stem cells and cancer share common factors, including DPPA2 and DPPA4.
- DPPA2 and DPPA4 are highly expressed in stem cells and reactivated in cancer.
- Previous studies showed DPPA2/DPPA4 knockout caused developmental defects, not affecting pluripotency.
Purpose of the Study:
- To clarify the functions of DPPA2 and DPPA4 in chromatin regulation and cell reprogramming.
- To understand the role of DPPA2 and DPPA4 at the pluripotency-differentiation boundary.
- To explore the relevance of DPPA2/DPPA4 functions in cancer.
Main Methods:
- Recent research has elucidated the roles of DPPA2 and DPPA4.
- Studies involved chromatin priming and regulation of histone modifications (H3K4me3, H3K27me3).
- Chromatin remodeling and induced pluripotency reprogramming were investigated.
Main Results:
- DPPA2 and DPPA4 regulate H3K4me3 and H3K27me3 at bivalent chromatin domains.
- These factors are involved in chromatin remodeling and somatic cell reprogramming.
- DPPA2 and DPPA4 play a key role in maintaining developmental competency.
Conclusions:
- DPPA2 and DPPA4 are critical regulators at the transition between pluripotency and differentiation.
- Their functions in stem cells may be relevant to their roles in cancer.
- These factors are important for chromatin dynamics and developmental potential.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Master Transcription Regulators
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Somatic to iPS Cell Reprogramming
Negative Regulator Molecules

